Extracorporeal Lithotripsy for Kidney Stones
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to break up kidney stones using sound waves, known as the Break Wave procedure (a type of extracorporeal lithotripsy). The goal is to determine the safety and effectiveness of this non-surgical approach for clearing kidney stones. Individuals with kidney stones visible on a CT scan, measuring 10 mm or less in the lower kidney or 20 mm or less elsewhere, may be suitable candidates. The trial monitors safety by tracking any complications and the need for additional treatment, and it assesses effectiveness by observing if stones pass naturally after the procedure. As an unphased trial, this study provides patients the chance to explore a potentially groundbreaking non-surgical treatment for kidney stones.
Will I have to stop taking my current medications?
If you are taking blood thinners (anticoagulants), you will need to stop them for the procedure. For other medications, the trial protocol does not specify, so it's best to discuss with the trial team.
What prior data suggests that the Break Wave technology is safe for breaking kidney stones?
Studies have shown that Extracorporeal Shock Wave Lithotripsy (ESWL), similar to the Break Wave technology being tested, is generally safe. This method uses shock waves to break kidney stones into smaller pieces. The procedure targets the stones accurately, usually avoiding harm to nearby organs and tissues.
Research indicates that ESWL has a low rate of serious side effects, meaning they are uncommon. However, some tissue damage may still occur. Most people handle the procedure well, and it is considered quick and simple.
While researchers continue to test the specific Break Wave technology in this trial, findings from similar treatments suggest it might also be safe and well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about Break Wave Extracorporeal Lithotripsy because it offers a non-invasive way to treat kidney stones using sound waves. Unlike traditional methods like surgery or invasive procedures that require anesthesia, this technique focuses on breaking down stones from outside the body, potentially reducing recovery time and hospital stays. Additionally, the precision of the sound waves targets only the stones, minimizing damage to surrounding tissues and making it a promising alternative for patients who can't undergo surgery.
What evidence suggests that the Break Wave technology is effective for breaking kidney stones?
Studies have shown that Break Wave Extracorporeal Lithotripsy, the investigational treatment in this trial, effectively treats kidney stones. In one study, 92% of patients experienced their kidney stones breaking into smaller pieces. Additionally, 75% of these patients had stone fragments measuring 4 mm or smaller. This indicates the treatment effectively breaks down stones for easier passage from the body. The procedure is also considered safe, with few reported complications. These findings make Break Wave a promising option for those dealing with stubborn kidney stones.26789
Are You a Good Fit for This Trial?
This trial is for adults with kidney stones visible on CT scans, located in the upper urinary tract and fitting within specific size guidelines (≤10 mm for lower pole stones, ≤20 mm for others). It's not suitable for those with certain health risks, untreated infections, bleeding disorders, pregnancy, or if they can't stop blood thinners. Vulnerable individuals and minors are also excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo the Break Wave procedure for urinary tract stone fragmentation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including adverse events and stone passage
What Are the Treatments Tested in This Trial?
Interventions
- Break Wave Extracorporeal Lithotripsy
Find a Clinic Near You
Who Is Running the Clinical Trial?
SonoMotion
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator